Skip to main content
SpringerLink
Log in

Serum levels of the soluble adhesion molecules in patients with malignant melanoma

  • Article
  • Published:
Pathology Oncology Research

Abstract

The incidence of malignant melanoma has been steadily increasing over the past decades. CD 44 is a transmembrane glycoprotein which is implicated in a number of adhesive and migratory events. Downregulation of CD 44 is implicated in the metastatic process. P-Selectin is a member of the selectin family of cell surface molecules. The levels of P-Selectin in biological fluids may be elevated in subjects with a variety of pathological conditions. In malignant melanoma, elevation of the plasma level of soluble intercellular adhesion molecule-1 (sICAM-1) has been associated with a reduction in disease-free survival. This study was performed to investigate the differences in the serum concentrations of the adhesion molecules in patients with malignant melanoma.The study group consisted of 52 patients with malignant melanoma and 20 healthy subjects. No meaningful difference was observed for P-selectin and sICAM 1 levels. A statistically significant decrease was observed in the cancer patients for serum CD 44 levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Altemonte M, Colizzi F, Esposito G, et al: Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 327–959, 1992.

  2. Borland G, Ross JA, Guy K: Forms and function of CD 44. Immunology 9:139–148, 1998.

    Article  Google Scholar 

  3. Guo YJ, Ma J, Wang JH, et al: Inhibition of human melanoma growth and metastasis in vitro by anti CD 44 monoclonal antibody. Cancer Res 54:1561–1565, 1994.

    PubMed  CAS  Google Scholar 

  4. Harning R, Mainolfi E, Bystryn JC, et al: Serum levels of circulating ICAM-1 in human melanoma. Cancer Res 51:5003–5005, 1991.

    PubMed  CAS  Google Scholar 

  5. Hart I, Birch M, Marshall JF: Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev 10:115–130, 1991.

    Article  PubMed  CAS  Google Scholar 

  6. Haynes BF, Hale LP, Patton KL, et al: Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum 34:1434–1443, 1991.

    PubMed  CAS  Google Scholar 

  7. Herrlich P, Zöller M, Palls ST, et al: CD 44 splice variants: metastases meet lymphocytes. Immunol Today 14:395–399, 1993.

    Article  PubMed  CAS  Google Scholar 

  8. Kageshlta T, Yoshii A, Kimura T, et al: Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 53:4927–4932, 1993.

    Google Scholar 

  9. Letner C: Introduction to statistics statistical tables: Geigy scientific tables. CIBA-GEIGY Ltd. Basel, Switzerland, 93:1982.

    Google Scholar 

  10. Ley K, Tedder TF: Leukocyte interactions with vascular endothelium. New insights into selectin-mediated attachment and rolling. J Immunol 155:525–530, 1995.

    PubMed  CAS  Google Scholar 

  11. Mackay CR, Terpe HJ, Stauder R, et al: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71–82, 1994.

    Article  PubMed  CAS  Google Scholar 

  12. Manten-Horst E, Danen EHJ, Smit L, et al: Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 64:182–188, 1995.

    Article  PubMed  CAS  Google Scholar 

  13. Nooijen PT, Westphal JR, Eggermont AM, et al: Endothelial PSelectin expression is reduced in advanced primary melanoma and melanoma metastasis. Am J Pathol 152:679–682, 1998.

    PubMed  CAS  Google Scholar 

  14. Price EA, Coombe DR, Murray JC: Endothelial CD 44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro. Int J Cancer 64:513–518, 1996.

    Article  Google Scholar 

  15. Ristamaki R, Joensuu H, Jalkanen S Does soluble CD44 reflect the clinical behavior of human cancer. Curr Top Microbiol Immunol 213:155–166, 1996.

    PubMed  CAS  Google Scholar 

  16. Schadendorf D, Heidel J, Gawlik C, et al: Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-Selectin and E-Selectin on intratumoral vessels. J Natl Cancer Inst 87:366–371, 1995.

    Article  PubMed  CAS  Google Scholar 

  17. Schadendorf D, Diehl S, Zuberbier T, et al: Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology 192:89–93, 1996.

    Article  PubMed  CAS  Google Scholar 

  18. Sliutz G, Temfer C, Winkler S, et al: Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Br J Cancer 72:1494–1497, 1995.

    PubMed  CAS  Google Scholar 

  19. Sy MS, Mori H, Liu D: CD44 as a marker in human cancers. Curr Opinion Oncol 9:108–112, 1997.

    Article  CAS  Google Scholar 

  20. Tan PH, Santos EB, Rossbach HC, et al: Enhancement of natural killer activity by an antibody to CD 44. J Immunol 150:812–820, 1993.

    PubMed  CAS  Google Scholar 

  21. Tedder TF: The selectins: Vascular adhesion molecules. FASEB J 9:866, 1995.

    PubMed  CAS  Google Scholar 

  22. Viac J, Gueniche A, Faure M, Claudy A. Soluble intercellular adhesion molecule 1 and malignant melanoma. Cancer Lett 72:191–194, 1993.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Basic Oncology, Oncology Institute, 34390, Capa, Istanbul, Turkey

    Vildan Yasasever, Faruk Tas, Derya Duranyildiz, Hakan Camlica, Sidika Kurul & Nejat Dalay

Authors
  1. Vildan Yasasever
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Faruk Tas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Derya Duranyildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hakan Camlica
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sidika Kurul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nejat Dalay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nejat Dalay.

Additional information

This work has been supported by the Istanbul University Research Fund (Project Nr. 1017/250897).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yasasever, V., Tas, F., Duranyildiz, D. et al. Serum levels of the soluble adhesion molecules in patients with malignant melanoma. Pathol. Oncol. Res. 6, 42–45 (2000). https://doi.org/10.1007/BF03032657

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032657

Keywords

Search

Navigation